- Non-invasive prenatal testing (NIPT)
- Pre-implantation genetic screening (PGS)
- Pre-implantation genetic diagnosis (PGD)
- BRCA 1 & 2 panel
- Cancer hotspot panel
- Lung Cancer mutation panel
- RAS Extended Plus for Colorectal Cancer
- Thyroid cancer mutation profile
- AML mutation panel
- GIST mutation panel
- Prostate cancer mutation panel
- ABL1 TKI resistance mutations
- MPN mutations
- TP53 mutation
- GIST mutation panel
- IDH1 & IDH2 mutations for glioma
- KIT D816V mutation
- FGFR3 mutation for bladder cancer
- BCR-ABL detection
- PML-RARA detection
- ALL translocation panel
- AML translocation panel
- HLA typing
- Paternity testing
Pre-implantation genetic diagnosis (PGD)
Pre-implantation genetic diagnosis (PGD)
Pre-implantation genetic diagnosis (PGD, also called PGT-M) is designed to identify embryos with inherited genetic abnormalities. These abnormalities (eg: thalassemia), present in one or both parents, could be passed to embryos. During PGD, a small number of cells are removed from the embryo, and the DNA is tested to identify the embryos that have not got the disease gene from the parents.
Couples who choose PGD could usually conceive naturally, but are using IVF specifically so that they can have healthy babies, and prevent passing on of the abnormal genes to subsequent generations.